The US Food and Drug Administration (FDA) has approved onabotulinumtoxinA (Botox, Allergan) to ease upper limb spasticity in children and adolescents aged 2 to 17 years, the company announced. Common ...

Merz Therapeutics announced the FDA approved a label update to expand incobotulinumtoxinA’s pediatric upper limb spasticity ...

— Achieved key co-primary endpoint on efficacy, with 500U dose demonstrating statistically significant difference from placebo in the Modified Ashworth Score (MAS) improvement from baseline — ...

(1) Assess the feasibility of a full-scale trial of intermittent theta-burst stimulation (iTBS) for upper-limb sensorimotor dysfunction following spinal cord injury (SCI). (2) Determine the safety and ...

Merz Therapeutics to present 11 abstracts at ISPRM World Congress 2026, highlighting its commitment to improving outcomes for people living with movement disorders Updated analysis indicates that ...

Expert Rev Neurother. 2009;9(12):1713-1725. The first patients with squint were successfully treated in 1977 [17] and since then botulinum toxin type A delivered by local injection has been used in ...

A advancement in the diagnosis of upper limb (UL) spasticity is on the horizon, moving beyond traditional reliance on clinicians' tactile assessments. Researchers affiliated with UNIST have developed ...

Henry Winkler, known for his television role as Arthur "The Fonz" Fonzarelli, made it a happy day for many people in the Triangle Tuesday who suffer from upper limb spasticity. Henry Winkler, known ...

Dysport is indicated for the treatment of both upper and lower limb spasticity in children aged 2 years and older The Food and Drug Administration (FDA) has expanded the indication of Dysport ...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC), a commercial stage biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced an ...

To explore effect of a focal, self-applied upper extremity (UE) vibration intervention on UE spasticity for individuals with tetraplegia. The secondary objectives were to explore the acceptability and ...